Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The number of dermatologists in the US increased from 1995 to 2011, but they were unevenly distributed, mainly in urban areas, and areas with higher income and education levels.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Hair loss linked to higher heart disease risk in both men and women.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.